rehabilitation
OtherAll patients addressing intemsive inpatient post stroke rehabilitation undergo a shared evidence based Integrated Care pathway that is routinely adopted in all the participating Centres
NCT Number: NCT05389878
Pathology registers are scientific research tools for the development of epidemiological and clinical studies and health planning, which allows access to useful elements for planning adequate health services. The Registry collects demographic, clinical and functional data of stroke patients and arises from the need to order and update this information for epidemiological and research purposes, for a better knowledge of this pathology from a rehabilitation point of view and to accelerate the development of new treatments.
Interested in participating?
Request Info18 year and older
All sexes
Observational
IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy
The Italian Society of Physical and Rehabilitation Medicine has published a minimal assessment protocol for stroke patients1 (PMIC2020) to share the evaluation of stroke rehabilitation needs and outcomes at any time of the rehabilitation pathway, as grounds for a National Stroke Rehabilitation Registry (SRR).
The STRATEGY multicentric study aims to verify the feasibility of implementing a PMIC2020-based SRR in a routine clinical setting, and develop data-driven prognosis prediction models.
Demographic, functional and clinical variables will be collected at the admission and the discharge of the patient; in addition, two telephone follow-ups (three months and six months from the event) will be carried out
The study will involve several rehabilitation centers of the Don Gnocchi Foundation, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All patients addressing intemsive inpatient post stroke rehabilitation undergo a shared evidence based Integrated Care pathway that is routinely adopted in all the participating Centres
Time frame: Admission, discharge (average 30 days from admission), follow-up (6 months after stroke)
measure of ability in activity of daily living range 0 worst- 100 best
Time frame: Admission, discharge (average 30 days from admission), follow-up (6 months after stroke)
measure of global disability range 0 best-5 worst
Time frame: Admission, discharge (average 30 days from admission), follow-up (6 months after stroke)
measure of functional ambulation range 0 worst- 6 best
Time frame: Admission, discharge (average 30 days from admission)
measure of trunk control range 0 worst- 100 best
Time frame: Admission, discharge (average 30 days from admission)
measure of lower limbs physical performance range 0 worst-12 best
Time frame: Admission, discharge (average 30 days from admission)
Measure of motricity in upper and lower limb range 0 worst-100 best
Time frame: Admission, discharge (average 30 days from admission)
Measure of upper and lower limb spasticity range range 0 best 100
Time frame: Admission, discharge (average 30 days from admission)
Cogntive level, range from 0 worst - 30 best
Contact information is provided by the study sponsor or research team.
Fondazione Don Carlo Gnocchi ETS
Other
STroke RehabilitATion rEgistrY for Predicting Functional Outcomes
Acronym: STRATEGY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06615973
Brain Disease, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT05378035
Arrhythmias, Cardiac, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT03821129
Brain Diseases, Cardiovascular Abnormalities
Tucson, Arizona, United States
View Trial DetailsNCT07737431
Brain Diseases, Cardiovascular Diseases
Hung Hom, Kowloon, Hong Kong
View Trial Details